214 related articles for article (PubMed ID: 23489866)
1. Prognostic and diagnostic significance of annexin A2 in colorectal cancer.
Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C
Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866
[TBL] [Abstract][Full Text] [Related]
2. Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.
Elzagheid A; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
APMIS; 2012 Jul; 120(7):539-48. PubMed ID: 22716209
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
[TBL] [Abstract][Full Text] [Related]
4. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
6. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
7. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
8. TUFM is a potential new prognostic indicator for colorectal carcinoma.
Shi H; Hayes M; Kirana C; Miller R; Keating J; Macartney-Coxson D; Stubbs R
Pathology; 2012 Oct; 44(6):506-12. PubMed ID: 22772342
[TBL] [Abstract][Full Text] [Related]
9. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
10. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
12. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
[TBL] [Abstract][Full Text] [Related]
14. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
15. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
18. Prognostic features of Annexin A2 expression in prostate cancer.
Tan SH; Young D; Chen Y; Kuo HC; Srinivasan A; Dobi A; Petrovics G; Cullen J; Mcleod DG; Rosner IL; Srivastava S; Sesterhenn IA
Pathology; 2021 Feb; 53(2):205-213. PubMed ID: 32967771
[TBL] [Abstract][Full Text] [Related]
19. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
Pancione M; Forte N; Campione S; Napolitano A; Parente D; Sabatino L; Febbraro A; Colantuoni V
Pathologica; 2010 Apr; 102(2):51-6. PubMed ID: 23596757
[TBL] [Abstract][Full Text] [Related]
20. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
